thanks SoT.
Project risk runs high when we fall behind schedule, in this case overtaken by comeptitors. A key reason why I took part in the 17c raise back in Oct 20 was due to the CNS potential.
I’m glad some have made it through, but still crushed that we couldn’t file the showstopper ALS lead IP documents earlier, Sahm had talked about it throughout 2021, saying it was weeks away during the US investor roadshow.
from Oct 2020 cap raise presentation
from AGM Nov 20 outlining multiple high value CNS leads
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.15 |
Change
0.020(1.77%) |
Mkt cap ! $670.7M | |||
| Open | High | Low | Value | Volume |
| $1.15 | $1.18 | $1.11 | $172.3K | 151.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 592 | $1.15 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.16 | 4211 | 1 |
View Market Depth
| Last trade - 16.10pm 20/06/2025 (20 minute delay) ? |
| PYC (ASX) Chart |